B. Braun Signs U.S. Distribution Agreement with RyMed Technologies for Its InVision-Plus® Neutral IV Connector - 47 ABC - Delmarva's Choice

B. Braun Signs U.S. Distribution Agreement with RyMed Technologies for Its InVision-Plus® Neutral IV Connector

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE B. Braun Medical Inc.

Neutral displacement line adds to B. Braun's expanding portfolio

BETHLEHEM, Pa. and AUSTIN, Texas, Sept. 2, 2014 /PRNewswire/ -- B. Braun Medical Inc. (B.Braun) and RyMed Technologies, LLC announced today that they have entered into a long-term distribution agreement for the InVision-Plus® Neutral IV Connector.

"The InVision-Plus Neutral IV Connector with Neutral Advantage Technology is designed to inhibit migration of bacteria into the fluid pathway, potentially improving patient outcomes, and enhancing clinician safety," said Tom Sutton, Vice President of Vascular Access Systems at B.Braun. "This agreement will complement B.Braun's current needleless connector portfolio offering to include a neutral displacement line of products," added Sutton.

The InVision-Plus Neutral IV Connector provides a priming volume of 0.027 mL. RyMed's InVision-Plus platform of products provide a 10-point standard of features.   

"We are extremely pleased to enter into this agreement with B.Braun, one of the finest companies in IV fluid delivery. RyMed first introduced neutral displacement technology to the market in 2004, and with this agreement, we will be able to offer the InVision-Plus System to a broader audience via B.Braun's customers and GPO contracts," said Dana Ryan, President & CEO of RyMed Technologies, LLC.

About B. Braun
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun Group of Companies in the U.S. includes B.Braun, B.Braun Interventional Systems, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 50,000 employees in more than 60 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com

About RyMed Technologies, LLC
RyMed Technologies, LLC specializes in the development and marketing of innovative safety products in the field of intravenous catheter care and maintenance. The company's products are designed to help reduce catheter-related bloodstream infections (CR-BSIs) and intraluminal thrombotic catheter occlusions associated with vascular access. More than 10 years of research and development have gone into InVision-Plus®.

The company is headquartered in Franklin, TN. For more information, call (512) 301-7334 or access www.rymedtech.com.

CMC Consulting Group advised RyMed in the transaction.

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
Powered by WorldNow All content © Copyright 2000 - 2014 WorldNow and WMDT. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.